RESUMEN
Individuals with bleeding tendencies are more likely to have blood type O than blood types A, B, or AB. Platelet storage pool deficiencies are a lesser-known group of bleeding disorders which often go undiagnosed and may account for a significant number of patients with unexplained bleeding defects. We hypothesized that patients with platelet δ-storage pool deficiency might also have a predominance of type O blood. A retrospective review of medical records of 2,020 patients with unexplained bleeding and evaluated for δ-storage pool deficiency was performed. Correlations between dense granule numbers, blood type, and von Willebrand factor were analyzed for statistical differences. 51.5% of blood samples were blood type O compared to an incidence of 44.0% in the U.S. population. There was a significant association of vWF and blood type O but not with the delta storage pool. There is a preponderance of blood type O in the study population compared to the U.S. population. There is no statistically significant link between blood type O and lower dense granule numbers in this study.
Asunto(s)
Sistema del Grupo Sanguíneo ABO/sangre , Plaquetas/ultraestructura , Agregación Plaquetaria/fisiología , Deficiencia de Almacenamiento del Pool Plaquetario/sangre , Factor de von Willebrand/metabolismo , Adulto , Tiempo de Sangría , Femenino , Humanos , Masculino , Microscopía Electrónica , Deficiencia de Almacenamiento del Pool Plaquetario/patología , Estudios RetrospectivosAsunto(s)
Sangre Fetal/trasplante , Deficiencia de Almacenamiento del Pool Plaquetario/terapia , Niño , Trasplante de Células Madre de Sangre del Cordón Umbilical/efectos adversos , Trasplante de Células Madre de Sangre del Cordón Umbilical/métodos , Enfermedad Injerto contra Huésped/etiología , Enfermedad Injerto contra Huésped/prevención & control , Humanos , Masculino , Deficiencia de Almacenamiento del Pool Plaquetario/sangre , Deficiencia de Almacenamiento del Pool Plaquetario/diagnóstico , Deficiencia de Almacenamiento del Pool Plaquetario/genéticaAsunto(s)
Deficiencia de Almacenamiento del Pool Plaquetario , Púrpura , Enfermedades de la Piel , Niño , Femenino , Humanos , Deficiencia de Almacenamiento del Pool Plaquetario/sangre , Deficiencia de Almacenamiento del Pool Plaquetario/diagnóstico , Deficiencia de Almacenamiento del Pool Plaquetario/patología , Púrpura/sangre , Púrpura/diagnóstico , Púrpura/patología , Enfermedades de la Piel/sangre , Enfermedades de la Piel/diagnóstico , Enfermedades de la Piel/patologíaRESUMEN
The article reviews three recent publications addressing physiological and pathological aspects of platelet granules and release as well as limitations of recent screening tests for diagnosis of non-syndromic inherited δ-storage pool disease (1-3).
Asunto(s)
Plaquetas/fisiología , Vesículas Secretoras/fisiología , Diagnóstico Diferencial , Síndrome de Plaquetas Grises/sangre , Síndrome de Plaquetas Grises/diagnóstico , Humanos , Deficiencia de Almacenamiento del Pool Plaquetario/sangre , Deficiencia de Almacenamiento del Pool Plaquetario/diagnósticoRESUMEN
Delta-granule platelet storage pool deficiency (δ-PSPD) is a poorly studied bleeding diathesis resulting from either decreased granule content or decreased average number of platelet δ-granules. Light transmission aggregometry (LTA) is commonly used to evaluate for δ-PSPD and platelet electron microscopy (EM) is used to confirm the diagnosis. Currently, little data exist examining the relationship between the likelihood of abnormal platelet aggregation findings, severity of δ-granule deficiency on platelet EM, and severity of bleeding symptoms in patients with δ-PSPD. Patients diagnosed with δ-PSPD by platelet EM who also underwent LTA testing were identified at a single institution for correlation between severity of bleeding, average number of platelet δ-granules, and number of agonist abnormalities on LTA. No statistically significant association was identified between the average number of δ-granules per platelet and likelihood of an abnormal LTA. LTA abnormalities were quite varied and only 50% diagnosed with δ-PSPD on EM had abnormal aggregation testing. Also, no correlation was seen between the number of clinical bleeding symptoms, number of average δ-granules per platelet, and the number of LTA agonist abnormalities. Our findings highlight the difficulties inherent in the laboratory evaluation of platelet function.
Asunto(s)
Agregación Plaquetaria , Deficiencia de Almacenamiento del Pool Plaquetario/sangre , Adenosina Difosfato/sangre , Adenosina Trifosfato/sangre , Adolescente , Niño , Preescolar , Femenino , Humanos , Masculino , Estudios Retrospectivos , Índice de Severidad de la Enfermedad , Adulto JovenRESUMEN
Platelet storage pool disease (SPD) is a platelet function disorder characterized by a reduction in the number or content of α-granules, dense granules, or both, and is diagnosed by specialized tests. Patients with SPD often present with prolonged bleeding time (BT), but the sensitivity and reproducibility of this test have limitations, often resulting in false negatives. It has recently been reported that an automated microchip flow-chamber system (T-TAS(®)) is useful in the assessment of anti-platelet therapy, and could have potential as a screening test for SPD. We examined the utility of T-TAS in three individuals from one family diagnosed with δ-SPD. The propositus had a mildly prolonged BT, and the standard tests for platelet function were close to the normal range. Whole blood samples were anti-coagulated with hirudin and applied to T-TAS microchips coated with collagen (PL-chips) at shear rates of 1000 and 2000 s(-1). Platelet thrombus formation (PTF) was monitored with a pressure sensor. Markedly depressed PTF was observed in all cases at both shear rates. These findings indicate that T-TAS is highly sensitive to the defect in these patients with SPD, and may represent a good candidate screening test for a wide range of platelet function disorders.
Asunto(s)
Procedimientos Analíticos en Microchip/métodos , Pruebas de Función Plaquetaria/instrumentación , Pruebas de Función Plaquetaria/métodos , Deficiencia de Almacenamiento del Pool Plaquetario/sangre , Deficiencia de Almacenamiento del Pool Plaquetario/diagnóstico , Estudios de Casos y Controles , Niño , Pruebas Hematológicas , Humanos , Masculino , Agregación PlaquetariaRESUMEN
Delta storage pool deficiency (δ-SPD) is a rare heterogeneous group of platelet disorders characterized by a reduction in the number or content of dense granules. δ-SPD causes a mild to moderate bleeding diathesis characterized mainly by mucocutaneous bleeding. Currently, no specific treatment is available and the therapeutic approach is based on prevention of excessive bleeding. However, during the last few years, important insights into the pathophysiology of δ-SPD have been achieved using mouse models and dense granule deficiency-associated congenital diseases, such as Hermansky-Pudlak syndrome and Chediak-Higashi syndrome. It thus appears that δ-SPD represents a genetically heterogeneous group of intracellular vesicle biogenesis and/or trafficking disorders. This review summarizes recent data regarding the molecular mechanisms together with clinical features of the different types of δ-SPD. Although the molecular basis of isolated inherited δ-SPD remains currently unknown, next-generation sequencing strategies should enable researchers to identify the causative genes. Identification of those genes should contribute to our understanding of the pathophysiology, represent useful tools for genetic diagnosis, and eventually lead to new specific therapeutic approaches.
Asunto(s)
Deficiencia de Almacenamiento del Pool Plaquetario/genética , Animales , Síndrome de Chediak-Higashi/sangre , Síndrome de Chediak-Higashi/genética , Síndrome de Chediak-Higashi/patología , Síndrome de Hermanski-Pudlak/sangre , Síndrome de Hermanski-Pudlak/genética , Síndrome de Hermanski-Pudlak/patología , Humanos , Deficiencia de Almacenamiento del Pool Plaquetario/sangre , Deficiencia de Almacenamiento del Pool Plaquetario/patologíaRESUMEN
We present the first thrombelastographic descriptions of three patients with δ-storage pool deficiency, a platelet disorder that involves a deficiency of dense granules and moderate bleeding. The patients demonstrated a 49-54% loss of platelet-mediated clot strength over a 1-2-h period after normal thrombus formation. This pattern persisted, with some attenuation of loss of strength following administration of epsilon aminocaproic acid, desmopressin and platelets for tonsillectomy. Assessment of platelet function in patients with platelet granule disorders can be accomplished with thrombelastographic methods in ambulatory and perioperative settings; however, the effects of therapy for this disorder cannot be monitored with thrombelastography without obtaining a blood sample prior to prophylactic hemostatic intervention.
Asunto(s)
Plaquetas/efectos de los fármacos , Hemostasis/efectos de los fármacos , Hemostáticos/administración & dosificación , Deficiencia de Almacenamiento del Pool Plaquetario/sangre , Deficiencia de Almacenamiento del Pool Plaquetario/tratamiento farmacológico , Tromboelastografía/métodos , Adolescente , Ácido Aminocaproico/administración & dosificación , Ácido Aminocaproico/uso terapéutico , Plaquetas/metabolismo , Gránulos Citoplasmáticos , Desamino Arginina Vasopresina/administración & dosificación , Desamino Arginina Vasopresina/uso terapéutico , Femenino , Fibrinólisis/efectos de los fármacos , Hemostáticos/uso terapéutico , Humanos , Masculino , Agregación Plaquetaria/efectos de los fármacos , Recuento de Plaquetas , Deficiencia de Almacenamiento del Pool Plaquetario/diagnóstico , Deficiencia de Almacenamiento del Pool Plaquetario/fisiopatología , Transfusión de Plaquetas , TonsilectomíaAsunto(s)
Deficiencia de Almacenamiento del Pool Plaquetario/genética , Proteínas de Unión al GTP rab/genética , Adulto , Niño , Preescolar , Análisis Mutacional de ADN , Femenino , Pruebas Genéticas , Humanos , Masculino , Mutación , Agregación Plaquetaria/genética , Deficiencia de Almacenamiento del Pool Plaquetario/sangre , Deficiencia de Almacenamiento del Pool Plaquetario/clasificaciónRESUMEN
We describe the peripartum management of a 26-year-old primigravida with a platelet storage pool disorder who underwent spontaneous vaginal delivery of twins with epidural analgesia. Postpartum hemorrhage from uterine atony, and cervical and vaginal lacerations were treated successfully with 1-desamino-8D-arginine vasopressin and blood products. The use of thromboelastography in the assessment and management of bleeding risk in the setting of platelet storage pool disorder is described.
Asunto(s)
Deficiencia de Almacenamiento del Pool Plaquetario/sangre , Hemorragia Posparto/terapia , Complicaciones del Embarazo/sangre , Tromboelastografía/métodos , Adulto , Desamino Arginina Vasopresina/uso terapéutico , Femenino , Humanos , Periodo Periparto , Deficiencia de Almacenamiento del Pool Plaquetario/complicaciones , EmbarazoRESUMEN
Inherited thrombocytopathies are much less frequent in comparison to acquired platelet function disorders. However, congenital disorders can lead to severe bleeding tendency and are often not diagnosed. They are induced by different platelet defects based on disorders of platelet adhesion, receptors, secretion and signal transduction. In some cases they are associated with thrombocytopenia, giant platelets and various comorbidities. This article gives an overview regarding diverse defects, their diagnosis and treatment options.
Asunto(s)
Trastornos de las Plaquetas Sanguíneas/genética , Plaquetas/fisiología , Genotipo , Trastornos Hemorrágicos/genética , Síndrome de Bernard-Soulier/sangre , Síndrome de Bernard-Soulier/diagnóstico , Síndrome de Bernard-Soulier/genética , Síndrome de Bernard-Soulier/terapia , Trastornos de las Plaquetas Sanguíneas/sangre , Trastornos de las Plaquetas Sanguíneas/diagnóstico , Trastornos de las Plaquetas Sanguíneas/terapia , Plaquetas/patología , Diagnóstico Diferencial , Trastornos Hemorrágicos/sangre , Trastornos Hemorrágicos/diagnóstico , Trastornos Hemorrágicos/terapia , Humanos , Tamizaje Masivo , Agregación Plaquetaria/genética , Agregación Plaquetaria/fisiología , Pruebas de Función Plaquetaria , Deficiencia de Almacenamiento del Pool Plaquetario/sangre , Deficiencia de Almacenamiento del Pool Plaquetario/diagnóstico , Deficiencia de Almacenamiento del Pool Plaquetario/genética , Deficiencia de Almacenamiento del Pool Plaquetario/terapia , Prostaglandina-Endoperóxido Sintasas/genética , Receptores de Colágeno/genética , Receptores de Colágeno/fisiología , Trombastenia/sangre , Trombastenia/diagnóstico , Trombastenia/genética , Trombastenia/terapia , Tromboxano-A Sintasa/genéticaRESUMEN
Considerable progress has been made over the last two decades in delineating the key molecular events regulating the haemostatic function of platelets. Much of this new insight has been derived from the study of mouse models, in which the expression or structure of one or more platelet proteins has been genetically altered. Despite these advances on the research front, clinical progress in diagnosing patients with unexplained surgical bleeding or recurrent haemorrhage from mucocutaneous sites has been comparatively limited. There is a dearth of literature available to help physicians integrate and apply the burgeoning knowledge on platelet biology to diagnosing patients with atypical or unexplained platelet dysfunction. The purpose of this review is to summarise the major primary platelet disorders relevant to pathological bleeding in humans (excluding those primarily due to thrombocytopenia or acquired functional disorders), with a focus on lesions identified in mouse models that could represent candidate molecules for study in patients with impaired platelet function.
Asunto(s)
Plaquetas/fisiología , Hemostasis/fisiología , Animales , Trastornos de las Plaquetas Sanguíneas/sangre , Humanos , Ratones , Adhesividad Plaquetaria/fisiología , Agregación Plaquetaria/fisiología , Deficiencia de Almacenamiento del Pool Plaquetario/sangreRESUMEN
Genetic defects of the megakaryocyte lineage give rise to bleeding syndromes of varying severity. Blood platelets are unable to fulfill their hemostatic function of preventing blood loss on vessel injury. Spontaneous bleeding is mostly mucocutaneous in nature. Most studied are deficiencies of glycoprotein (GP) mediators of adhesion (Bernard-Soulier syndrome) and aggregation (Glanzmann thrombasthenia) which concern the GPIb-IX-V complex and the integrin alphaIIbbeta3, respectively. Defects of primary receptors for stimuli include the P2Y(12)ADP receptor pathology. Agonist-specific deficiencies in the platelet aggregation response and abnormalities of signaling pathways are common and lead to trauma-related bleeding. Inherited defects of secretion from storage organelles, of ATP production, and of the generation of procoagulant activity are also encountered. In some disorders, such as the Chediak-Higashi, Hermansky-Pudlak, Wiskott-Aldrich and Scott syndromes, the molecular lesion extends to other cells. In familial thrombocytopenia (FT), platelets are produced in insufficient numbers to assure haemostasis. Some of these disorders affect platelet morphology and give rise to the so-called 'giant platelet' syndromes (MYH9-related diseases) with changes in megakaryocyte maturation within the bone marrow and premature release of platelets. Diseases of platelet production may extend to other cells and in some cases interfere with development. Transfusion of platelets remains the most common treatment of severe bleeding, management with desmopressin is common for mild disorders. Substitute therapies are available including rFVIIa and the potential use of TPO analogues for FT. Stem cell or bone marrow transplanation is being used for severe diseases while gene therapy may be on the horizon.
Asunto(s)
Trastornos de la Coagulación Sanguínea Heredados/genética , Coagulación Sanguínea/genética , Plaquetas/metabolismo , Animales , Síndrome de Bernard-Soulier/sangre , Síndrome de Bernard-Soulier/genética , Trastornos de la Coagulación Sanguínea Heredados/sangre , Trastornos de la Coagulación Sanguínea Heredados/terapia , Plaquetas/enzimología , Gránulos Citoplasmáticos/metabolismo , Citoesqueleto/metabolismo , Humanos , Megacariocitos/metabolismo , Adhesividad Plaquetaria/genética , Deficiencia de Almacenamiento del Pool Plaquetario/sangre , Deficiencia de Almacenamiento del Pool Plaquetario/genética , Receptores de Colágeno/genética , Receptores de Colágeno/metabolismo , Receptores Purinérgicos/genética , Receptores Purinérgicos/metabolismo , Transducción de Señal/genética , Trombastenia/sangre , Trombastenia/genética , Trombocitopenia/sangre , Trombocitopenia/genética , Factores de Transcripción/genética , Factores de Transcripción/metabolismo , Enfermedades de von Willebrand/genética , Enfermedades de von Willebrand/metabolismoRESUMEN
Alpha-Delta platelet storage pool deficiency (alphadelta SPD) is a rare inherited bleeding disorder affecting both males and females, occurring in families, as well as sporadically. Patient platelets in most cases are moderately deficient in both alpha granules and dense bodies. Only one patient has been severely deficient in both organelles. The present study is the first to document a severe decrease in both platelet alpha granules and dense bodies in four members in three generations of the same family. Efforts to differentiate this disorder from other hypogranular platelets syndromes in the present investigation suggested that the alpha granules and dense bodies become connected to channels of the open canalicular system (OCS) and lose their contents to the exterior without prior activation of the cells. In contrast, alpha granule formation in the white platelet syndrome is too slow, and cells leave the bone marrow still in the process of producing organelles. Gray platelet syndrome platelets can make alpha granules, but their enclosing membranes are unable to retain stored products. As a result, the organelles lose their contents to surrounding cytoplasm in megakaryocytes and platelets, not selectively through the demarcation system channels and OCS channels. Thus, the pathogenesis of alphadelta SPD is unique.
Asunto(s)
Plaquetas/ultraestructura , Deficiencia de Almacenamiento del Pool Plaquetario/genética , Complicaciones Hematológicas del Embarazo/genética , Plaquetas/enzimología , Plaquetas/metabolismo , Colorantes/análisis , Femenino , Glicocálix/ultraestructura , Humanos , Recién Nacido , Masculino , Megacariocitos/patología , Menorragia/etiología , Modelos Biológicos , Osmio/análisis , Peroxidasa/sangre , Deficiencia de Almacenamiento del Pool Plaquetario/sangre , Deficiencia de Almacenamiento del Pool Plaquetario/complicaciones , Embarazo , Púrpura/etiología , Vesículas Secretoras/ultraestructuraRESUMEN
BACKGROUND: We report a novel case of gray platelet syndrome (GPS). A 14-year-old boy had bleeding diathesis, mild thrombocytopenia, giant platelets with severe defect of alpha-granule secretory proteins, myelofibrosis and splenomegaly. METHODS AND RESULTS: Platelet function studies showed a marked reduction of aggregation and Ca(2+) mobilization by thrombin, protease-activated receptor 1 (PAR1)-activating peptide (AP) and PAR4-AP, PAR1 expression at 55% of normal levels, and a more than two hundred fold reduction of in vitro whole-blood thromboxane B(2) (TXB(2)) production. Sequencing of coding regions of the PAR1 gene failed to show abnormalities. This patient was initially classified as a sporadic case of GPS, as electron microscopy failed to identify giant platelets and/or alpha-granule deficiency in his relatives. However, further studies on the father and three other relatives showed a relative lack of platelet alpha-granule proteins by immunofluorescence microscopy, a defective platelet response to PAR4-AP, and severely reduced in vitro whole-blood TXB(2) production. On this basis, we suggest that in this family, GPS was transmitted in a dominant fashion with highly variable penetrance. CONCLUSIONS: Our study suggests that current diagnostic criteria fail to identify some patients with a mild GPS phenotype and that such patients might be identified by the methods cited above. It also better characterizes the pathogenesis of defective platelet responses to thrombin, and raises interesting questions on the correlation between abnormal PAR function and the lack of alpha-granule content in GPS.
Asunto(s)
Plaquetas/efectos de los fármacos , Coagulantes/farmacología , Agregación Plaquetaria/efectos de los fármacos , Deficiencia de Almacenamiento del Pool Plaquetario/sangre , Receptor PAR-1/agonistas , Trombina/farmacología , Adolescente , Adulto , Anciano , Plaquetas/metabolismo , Plaquetas/ultraestructura , Señalización del Calcio/efectos de los fármacos , Gránulos Citoplasmáticos/ultraestructura , Familia , Femenino , Humanos , Masculino , Microscopía Fluorescente , Persona de Mediana Edad , Oligopéptidos/farmacología , Selectina-P/análisis , Linaje , Fenotipo , Factor Plaquetario 4/análisis , Pruebas de Función Plaquetaria , Deficiencia de Almacenamiento del Pool Plaquetario/diagnóstico , Deficiencia de Almacenamiento del Pool Plaquetario/genética , Deficiencia de Almacenamiento del Pool Plaquetario/metabolismo , Deficiencia de Almacenamiento del Pool Plaquetario/patología , Receptor PAR-1/genética , Receptor PAR-1/metabolismo , Síndrome , Trombospondina 1/análisis , Tromboxano B2/sangreRESUMEN
In the majority of patients with an inherited abnormality in platelet function and a bleeding diathesis, the underlying platelet molecular mechanisms are unknown. The usually considered entities, such as thrombasthenia, the Bernard-Soulier syndrome, and storage pool deficiency, occur in a small proportion of patients. A substantial number of patients present with decreased aggregation and secretion of dense granule contents upon activation, and are lumped in the category of primary secretion defects or platelet activation defects. Evidence is now available that defects in platelet signaling mechanisms may be the basis for the platelet dysfunction in some of these patients. This evidence is presented here. If the key components in signal transduction are the surface receptors, the G-proteins, and the effectors, evidence now exists for specific human platelet abnormalities at each of these levels. There is a pressing need for a concerted effort to delineate the molecular mechanisms in the large group of patients with impaired platelet function who represent an untapped reservoir of new information into normal platelet function.
Asunto(s)
Plaquetas/citología , Plaquetas/metabolismo , Ácido Araquidónico/metabolismo , Síndrome de Bernard-Soulier/sangre , Citoesqueleto/metabolismo , Activación Enzimática , Subunidades alfa de la Proteína de Unión al GTP Gs/metabolismo , Proteínas de Unión al GTP/metabolismo , Humanos , Isoenzimas/deficiencia , Modelos Biológicos , Fosfolipasa C beta , Deficiencia de Almacenamiento del Pool Plaquetario/sangre , Proteína Quinasa C/metabolismo , Transducción de Señal , Trombastenia/sangre , Tromboxano A2/metabolismo , Tromboxano-A Sintasa/metabolismo , Fosfolipasas de Tipo C/deficienciaRESUMEN
Human platelets are known to contain inherently electron-opaque dense bodies, the storage sites for adenine nucleotides and serotonin, which can be identified under the electron microscope without fixation or staining. Recently we have reported that platelets also contain chains and clusters that are also opaque when examined by the whole-mount technique. The possibility that the newly described structures might be stages in the development of dense bodies requires consideration. The present study examined platelets from patients with Hermansky-Pudlak syndrome, Chediak-Higashi syndrome and platelet storage pool disease, whose cells are markedly deficient or lack dense bodies. Platelets from these individuals contained the same frequency of chains and clusters as found in platelets from normal controls. Thus, chains and clusters do not appear related to formation of dense bodies.
Asunto(s)
Plaquetas/ultraestructura , Síndrome de Chediak-Higashi/sangre , Síndrome de Hermanski-Pudlak/sangre , Deficiencia de Almacenamiento del Pool Plaquetario/sangre , Donantes de Sangre , Plaquetas/metabolismo , Plaquetas/patología , Síndrome de Chediak-Higashi/patología , Síndrome de Hermanski-Pudlak/patología , Humanos , Microscopía Electrónica/métodos , Agregación Plaquetaria , Deficiencia de Almacenamiento del Pool Plaquetario/patologíaRESUMEN
Gray platelet syndrome (GPS) is a disorder characterized by thrombocytopenia and large platelets that lack alpha granules and their contents. We describe two siblings with GPS who are members of a Moslem Bedouin genetic isolate. The children, an 8-year-old girl and a 5-year-old boy, had characteristic pale blue platelets lacking alpha granules on electron microscopy. Platelet aggregation studies were normal. The girl underwent a bone marrow aspiration and biopsy which showed mild myelofibrosis and extensive emperipolesis, i.e., the passage of other hematopoietic cells through megakaryocytes. Both children lacked high-molecular-weight multimers of von Willebrand factor (vWF) and had reduced activity and antigens of vWf. Platelet activation was approximately normal when ADP was employed as agonist, but significantly impaired using the thrombin receptor-activating peptide (TRAP). These findings are explained in light of the mechanism of action of each agonist. In addition, we propose that the emperipolesis was caused by increased P-selectin in megakaryocytes, and resulted in release of fibroblastic growth factors, explaining the myelofibrosis. The detailed description of these cases provides a basis for future differentiation of the various types of GPS, and for our current attempts to isolate the gene causing GPS in this genetic isolate.